| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.1 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.048 | 0.1 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.059 | 0.1 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.45 | 0.1 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.1 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.054 | 0.1 |